{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:44:42Z","timestamp":1787755482167,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Backgrounds<\/jats:title>\n                <jats:p>In recent years, many studies have shown that insulin resistance is related to the occurrence of thyroid cancer, but there are few reports on whether the two are related under the premise that thyroid function is normal and the metabolic components related to insulin resistance are excluded. This study aims to analyze the insulin resistance of patients with differentiated thyroid cancer after excluding the population with abnormal metabolic components, and to study the risk factors of thyroid cancer in this population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>61 subjects diagnosed with differentiated thyroid carcinoma (DTC) formed the DTC group and 262 subjects with benign nodules formed the control group. Body mass index (BMI, kg\/m2), waist circumference (WC), lipid profiles, and free T3 (FT3), free T4 (FT4), thyroid-stimulating hormone (TSH), thyroid peroxidase antibody (TPOAb), thyroid globulin antibody (TGAb), alanine transaminase (ALT), aspartate aminotransferase (AST), fasting plasma glucose (FPG), fasting serum insulin and homeostatic model assessment of insulin resistance (HOMA-IR) levels were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mean subjects age (<jats:italic>P<\/jats:italic>\u2009=\u20090.021), BMI (<jats:italic>P<\/jats:italic>\u2009=\u20090.049), WC (<jats:italic>P<\/jats:italic>\u2009=\u20090.01), serum insulin concentration (<jats:italic>P<\/jats:italic>\u2009=\u20090.006), and HOMA-IR level (<jats:italic>P<\/jats:italic>\u2009=\u20090.005) were significantly greater in the DTC group than in the control group. Multivariate binary logistic regression analysis identified advanced age (OR\u2009=\u20091.027 [1.003\u20131.051], <jats:italic>P<\/jats:italic>\u2009=\u20090.029) and an increased HOMA-IR level (OR\u2009=\u20091.572 [1.277\u20131.935], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) as significant risk factors for thyroid cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IR may increase the risk of thyroid cancer development even in the absence of conditions affecting insulin resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-00943-6","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T21:02:37Z","timestamp":1646686957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Relationship between insulin resistance and thyroid cancer in Chinese euthyroid subjects without conditions affecting insulin resistance"],"prefix":"10.1186","volume":"22","author":[{"given":"Ning","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimiao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"9","key":"943_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C La Vecchia","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136(9):2187\u201395.","journal-title":"Int J Cancer"},{"issue":"21","key":"943_CR2","first-page":"283","volume":"22","author":"J Ma","year":"2015","unstructured":"Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit. 2015;22(21):283\u201391.","journal-title":"Med Sci Monit"},{"issue":"1","key":"943_CR3","doi-asserted-by":"publisher","first-page":"e14545","DOI":"10.5812\/ijem.14545","volume":"16","author":"Z Heidari","year":"2017","unstructured":"Heidari Z, Abdani M, Mansournia MA. Insulin Resistance Associated With Differentiated Thyroid Carcinoma: Penalized Conditional Logistic Regression Analysis of a Matched Case-Control Study Data. Int J Endocrinol Metab. 2017;16(1):e14545.","journal-title":"Int J Endocrinol Metab."},{"issue":"5","key":"943_CR4","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1007\/s11033-014-3218-2","volume":"41","author":"M Akker","year":"2014","unstructured":"Akker M, G\u00fcldiken S, Sipahi T, Palab\u0131y\u0131k O, Tosuno\u011flu A, \u00c7elik \u00d6, et al. Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer. Mol Biol Rep. 2014;41(5):3541\u20137.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"943_CR5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond). 2008;32(6):959\u201366.","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"943_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ijo.2010.5","volume":"34","author":"DO Okorodudu","year":"2010","unstructured":"Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes(Lond). 2010;34(5):791\u20139.","journal-title":"Int J Obes(Lond)"},{"issue":"7\u20138","key":"943_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bulcan.2019.04.008","volume":"106","author":"B Lauby-Secretan","year":"2019","unstructured":"Lauby-Secretan B, Dossus L, Marant-Micallef C, His M. Ob\u00e9sit\u00e9 et cancer [Obesity and Cancer]. Bull Cancer. 2019;106(7\u20138):635\u201346.","journal-title":"Bull Cancer."},{"issue":"10","key":"943_CR8","doi-asserted-by":"publisher","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"P Prasun","year":"2020","unstructured":"Prasun P. Mitochondrial dysfunction in metabolic syndrome. Biochimica etbiophysica acta-molecular basis of disease. 2020;1866(10):165838\u2013165838.","journal-title":"Biochimica etbiophysica acta-molecular basis of disease"},{"key":"943_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-42542-9_1","volume":"208","author":"T Pischon","year":"2016","unstructured":"Pischon T, Nimptsch K. Obesity and Risk of Cancer: An Introductory Overview. Recent Results Cancer Res. 2016;208:1\u201315.","journal-title":"Recent Results Cancer Res"},{"key":"943_CR10","doi-asserted-by":"publisher","unstructured":"Farahani H, Mahmoudi T, Asadi A, Nobakht H, Dabiri R, Hamta A. Insulin Resistance and Colorectal Cancer Risk: the Role of Elevated Plasma Resistin Levels. J Gastrointest Cancer. 2019 Jun 6:https:\/\/doi.org\/10.1007\/s12029-019-00260-7.","DOI":"10.1007\/s12029-019-00260-7"},{"issue":"3","key":"943_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s12253-019-00610-7","volume":"25","author":"MV Mart\u00edn-Manzo","year":"2019","unstructured":"Mart\u00edn-Manzo MV, Lara C, Vargas-de-Leon C, Carrero J, Queipo G, Fonseca-Sanchez M. Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells. Pathol Oncol Res. 2019;25(3):1233\u201343.","journal-title":"Pathol Oncol Res"},{"issue":"18","key":"943_CR12","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1016\/j.ejca.2015.08.031","volume":"51","author":"AV Hernandez","year":"2015","unstructured":"Hernandez AV, Pasupuleti V, Benites-Zapata VA, Thota P, Deshpande A, Perez-Lopez FR. Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis. Eur J Cancer. 2015;51(18):2747\u201358.","journal-title":"Eur J Cancer"},{"issue":"25","key":"943_CR13","doi-asserted-by":"publisher","first-page":"38959","DOI":"10.18632\/oncotarget.8341","volume":"7","author":"C Micucci","year":"2016","unstructured":"Micucci C, Valli D, Matacchione G, Catalano A. Current perspectives between metabolic syndrome and cancer. Oncotarget. 2016;7(25):38959\u201372.","journal-title":"Oncotarget"},{"issue":"8","key":"943_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fendo.2017.00314","volume":"14","author":"R Malaguarnera","year":"2017","unstructured":"Malaguarnera R, Vella V, Nicolosi ML, Belfiore A. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? Front Endocrinol (Lausanne). 2017;14(8):314.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"943_CR15","doi-asserted-by":"publisher","first-page":"e109852","DOI":"10.1371\/journal.pone.0109852","volume":"9","author":"CH Tseng","year":"2014","unstructured":"Tseng CH. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. PLoS One. 2014;9(10):e109852.","journal-title":"PLoS One"},{"issue":"7","key":"943_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"10","key":"943_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1055\/s-0043-117892","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li C, Zhao W, Wang Y. Hashimoto\u2019s Thyroiditis is an Important Risk Factor of Papillary Thyroid Microcarcinoma in Younger Adults. Horm Metab Res. 2017;49(10):732\u20138.","journal-title":"Horm Metab Res"},{"issue":"9","key":"943_CR18","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2337\/dc07-0649","volume":"30","author":"WA Banks","year":"2007","unstructured":"Banks WA, Willoughby LM, Thomas DR, Morley JE. Insulin resistance syndrome in the elderly: assessment of functional, biochemical, metabolic, and inflammatory status. Diabetes Care. 2007;30(9):2369\u201373.","journal-title":"Diabetes Care"},{"issue":"4","key":"943_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/EJE-09-0410","volume":"161","author":"S Ayturk","year":"2009","unstructured":"Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009;161(4):599\u2013605.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"943_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s12032-013-0589-5","volume":"30","author":"M Sahin","year":"2013","unstructured":"Sahin M, U\u00e7an B, Gini\u015f Z, Topalo\u011flu O, G\u00fcng\u00fcne\u015f A, Bozkurt N\u00c7, et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol. 2013;30(2):589.","journal-title":"Med Oncol"},{"issue":"1","key":"943_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1210\/jc.2014-2723","volume":"100","author":"K Wang","year":"2015","unstructured":"Wang K, Yang Y, Wu Y, Chen J, Zhang D, Mao X, et al. The association between insulin resistance and vascularization of thyroid nodules. J Clin Endocrinol Metab. 2015;100(1):184\u201392. https:\/\/doi.org\/10.1210\/jc.2014-2723.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"943_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12020-013-9942-x","volume":"45","author":"F Balkan","year":"2014","unstructured":"Balkan F, Onal ED, Usluogullari A, Tuzun D, Ozdemir D, Inancli SS, et al. Is there any association between insulin resistance and thyroid cancer?\u202f: A case control study. Endocrine. 2014;45(1):55\u201360.","journal-title":"Endocrine"},{"issue":"2","key":"943_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<492::AID-CNCR30>3.0.CO;2-I","volume":"85","author":"L Frittitta","year":"1999","unstructured":"Frittitta L, Sciacca L, Catalfamo R, Ippolito A, Gangemi P, Pezzino V, et al. Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis? Cancer. 1999;85(2):492\u20138.","journal-title":"Cancer"},{"issue":"6","key":"943_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1158\/1055-9965.EPI-13-1210-T","volume":"23","author":"JA Schmidt","year":"2014","unstructured":"Schmidt JA, Allen NE, Almquist M, Franceschi S, Rinaldi S, Tipper SJ, et al. Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2014;23(6):976\u201385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"943_CR25","doi-asserted-by":"publisher","unstructured":"Chen Z, Jiang X, Feng Y, Li X, Chen D, Mao Z, et al. DECREASE IN ACROMEGALY-ASSOCIATED THYROID ENLARGEMENT AFTER NORMALIZATION OF IGF-1 LEVELS: A PROSPECTIVE OBSERVATION AND IN VITRO STUDY. Endocr Pract. 2019 Dec 20:https:\/\/doi.org\/10.4158\/EP-2019-0353.","DOI":"10.4158\/EP-2019-0353"},{"issue":"5","key":"943_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1530\/EJE-14-0966","volume":"172","author":"L Curt\u00f2","year":"2015","unstructured":"Curt\u00f2 L, Giovinazzo S, Alibrandi A, Campenn\u00ec A, Trimarchi F, Cannav\u00f2 S, et al. Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study. Eur J Endocrinol. 2015;172(5):543\u201352.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"943_CR27","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1210\/jc.2007-0816","volume":"92","author":"H V\u00f6lzke","year":"2007","unstructured":"V\u00f6lzke H, Friedrich N, Schipf S, Haring R, L\u00fcdemann J, Nauck M, et al. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab. 2007;92(10):4039\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"943_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1210\/jc.2010-1255","volume":"96","author":"R Malaguarnera","year":"2011","unstructured":"Malaguarnera R, Frasca F, Garozzo A, Gian\u00ec F, Pandini G, Vella V, et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab. 2011;96(3):766\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"943_CR29","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/ERC-12-0203","volume":"19","author":"DP Rose","year":"2012","unstructured":"Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr Relat Cancer. 2012;19(6):R225\u201341.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"943_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2007.0223","volume":"18","author":"J Rezzonico","year":"2008","unstructured":"Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid. 2008;18(4):461\u20134.","journal-title":"Thyroid"},{"key":"943_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijsu.2018.07.013","volume":"57","author":"DT Yin","year":"2018","unstructured":"Yin DT, He H, Yu K, Xie J, Lei M, Ma R, et al. The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis. Int J Surg. 2018;57:66\u201375.","journal-title":"Int J Surg"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-00943-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T21:04:51Z","timestamp":1646687091000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-00943-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-00943-6","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration. The study was approved by the Ethics Committee of the Second Affiliated Hospital of Dalian Medical University. All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}